Stengone Carmine N.

Track

Insider profile

Stengone Carmine N.'s trades of Contineum Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-03 2026-08-03
PlS Planned sale
48,324 +17.7%
31.10
US$2,582,875 		48,324 +17.7% 31.10 US$2,582,875
2026-08-03 2026-08-03
PrS Proposed sale
96,674
17.91
US$428,797 		96,674 17.91 US$428,797
2026-07-08 2026-07-08
PlS Planned sale
5,677 -16.1%
315.94
US$1,083,108 		5,677 -16.1% 315.94 US$1,083,108
2026-07-08 2026-07-08
PrS Proposed sale
2,500
14.56
US$36,400 		2,500 14.56 US$36,400
2026-07-01 2026-06-30
PlS Planned sale
10,000 -36.7%
16.01
US$160,080 		10,000 -36.7% 16.01 US$160,080
2026-06-30 2026-06-30
PrS Proposed sale
10,000
15.00
US$150,000 		10,000 15.00 US$150,000
2026-02-26 2026-02-25
PlS Planned sale
2,700 -15.3%
16.02
US$43,242 		2,700 -15.3% 16.02 US$43,242
2026-02-26 2026-02-24
PlS Planned sale
4,400 -22.7%
16.02
US$70,486 		4,400 -22.7% 16.02 US$70,486
2026-02-13 2026-02-11
PlS Planned sale
400 -2.6%
16.00
US$6,400 		400 -2.6% 16.00 US$6,400
2026-02-11 2026-02-11
PrS Proposed sale
7,500
15.75
US$118,125 		7,500 15.75 US$118,125
2024-09-12 2024-09-11
B Purchase
1,250 +inf%
3.68
US$4,600 		1,250 +inf% 3.68 US$4,600